| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-16 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-15 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-13 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-11 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-11 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-11 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-10 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-10 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-10 |